Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating flexible dosing of paliperidone extended-release tablets in adults with schizophrenia has completed and …
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations [NA]
This entry notes the completion of a trial evaluating transcranial magnetic stimulation for persistent auditory hallucinations in schizophre…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia [Phase 3]
This update reports the completion and posted results of a Phase 3 trial evaluating the efficacy and safety of paliperidone ER tablets in sc…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia [NA]
This completed clinical trial investigated interventions aimed at improving functional outcomes and persistent symptoms in schizophrenia and…
-
FDA approval · 2013-07-30FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for Abilify (aripiprazole) by Otsuka America Pharmaceutical, Inc. The action results in updated labe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Improving Work Outcome in People With Recent-onset Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating methods to improve work outcomes in people with recent-onset schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders [Phase 4]
Phase 4 clinical trial update reporting efficacy and safety of Risperidone long-acting injectable in schizophrenia-spectrum disorders.
-
FDA approval · 2013-07-25FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for ziprasidone under an ANDA, indicating an approved change to the…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia [Phase 4]
Phase 4 clinical trial update evaluating switching from oral antipsychotics to long-acting risperidone in people with schizophrenia.
-
CLINICAL_TRIALS withdrawal · 2013-07-24Clinical Trial Update: Clozapine IM and Aggression in Schizophrenic Patients [Phase 3]
A Phase 3 trial evaluating intramuscular clozapine for aggression in schizophrenia was withdrawn.
-
CLINICAL_TRIALS research · 2013-07-24Clinical Trial Update: Bexarotene Treatment in Schizophrenia [Phase 3]
A Phase 3 clinical trial is evaluating bexarotene for schizophrenia. The trial status is listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia [NA]
The clinical trial evaluating transcranial direct current stimulation for negative symptoms in schizophrenia has completed.
-
FDA approval · 2013-07-19FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fanapt (iloperidone) submitted by Vanda Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia [Phase 3]
Phase 3 clinical trial update on an intramuscular depot formulation of aripiprazole for maintenance treatment in schizophrenia, with results…
-
CLINICAL_TRIALS research · 2013-07-19Clinical Trial Update: Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia
An update on a clinical trial studying social dysfunction and brain dysfunction in patients with schizophrenia. The update does not provide …
-
FDA approval · 2013-07-12FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
FDA approved a supplemental application for FANAPT (iloperidone) submitted by Vanda Pharmaceuticals Inc.
-
FDA approval · 2013-07-12FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) filed by Sumitomo Pharma America, Inc.
-
CLINICAL_TRIALS research · 2013-07-12Clinical Trial Update: A RCT Study in Schizophrenia Relapse Prevention [NA]
Clinical trial update for a randomized study in relapse prevention for schizophrenia; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia [Phase 3]
Phase 3 comparative trial evaluating paliperidone palmitate versus risperidone long-acting injection in adults with schizophrenia; results c…
-
CLINICAL_TRIALS withdrawal · 2013-07-08Clinical Trial Update: Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital [Phase 4]
Phase 4 study investigating paliperidone palmitate versus selected oral antipsychotics in adults with schizophrenia recently discharged from…
-
FDA approval · 2013-07-03FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2013-07-03FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved Viatris Specialty LLC's supplemental application for Geodon (ziprasidone).
-
CLINICAL_TRIALS research · 2013-07-03Clinical Trial Update: The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia
A completed clinical trial evaluating the genetic basis of inherited neurologic deficits in people with schizophrenia, conducted by the Univ…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Treating Drug-Resistant Childhood Schizophrenia [Phase 4]
A Phase 4 clinical trial addressing drug-resistant childhood schizophrenia has completed. The sponsor is Northwell Health.
-
FDA approval · 2013-06-28FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc.